DexCom, Inc. (FRA:DC4)

Market Cap	23.06B
Revenue (ttm)	3.90B
Net Income (ttm)	556.55M
Shares Out	n/a
EPS (ttm)	1.38
PE Ratio	41.44
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	338
Average Volume	117
Open	60.79
Previous Close	60.28
Day's Range	60.79 - 60.79
52-Week Range	52.00 - 127.64
Beta	n/a
RSI	42.43
Earnings Date	May 1, 2025

About DexCom

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1999
• Employees: 10,300
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: DC4

Financial Performance

In 2024, DexCom's revenue was $4.03 billion, an increase of 11.34% compared to the previous year's $3.62 billion. Earnings were $576.20 million, an increase of 6.41%.

Financial numbers in USD